189
Participants
Start Date
February 29, 2004
Primary Completion Date
June 30, 2005
Study Completion Date
September 30, 2005
degarelix
Degarelix was given as subcutaneous injections.
UCL Saint Luc, Brussels
UZ Gent, Ghent
UZ Gasthuisberg, Leuven
Vivantes Klinikum am Urban, Berlin
Loretto Krankenhaus, Freiburg im Breisgau
Euromed AG Klinik, Fürth
Urologische Universitätsklinikum, Mannheim
Bajcsy-Zsilinszky Hospital, Urology, Budapest
Jahn Ferenc Dél Pesti Hospital, Urology, Budapest
Pez Aladar County Hospital, Győr
BAZ County Hospital, Miskolc
Hospital of Local Gov. Szeged, Urology, Szeged
MÁV Hospital, Urology, Szolnok
AMC, Amsterdam
Atrium MC, Heerlen
Wojewódzki Szpital Specjalisttyczny, Siedlce
Wojewódzki Szpital Specjalisttyczny, Słupsk
CF2 Hospital, Bucharest
Dr. Th Burghele Hospital, Bucharest
Fundeni Hospital, Bucharest
Sf. Ioan Hospital, Bucharest
Botkin Clinical Hospital, Moscow
City Hospital #1, Moscow
City Hospital #29, Moscow
City Hospital #50, Moscow
City Hospital #60, Moscow
Institute of Urology of MoH, Moscow
"Andros Urology Clinic", Saint Petersburg
City Hospital #15, Saint Petersburg
City Hospital #26, Saint Petersburg
Military Medical Academy, Urology, Saint Petersburg
Pavlov Medical School Outpatient, Saint Petersburg
Pavlov medical School, Urology, Saint Petersburg
Sct Petersburg State Medical Academy, Saint Petersburg
370 Clarke Road, Glenwood, Durban
Pretoria Urology Hospital, Hatfield, Pretoria
WITS Medical School, Parktown
401B Medical Centre, Pietermaritzburg
Sunninghill Clinic, Sunninghill
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY